Treatment comparisons in HIV infection: the benefits and limitations of observational cohort studies

被引：15

作者：

Sabin, CA ^{[1
]}

Phillips, AN ^{[1
]}

机构：

[1] UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, Royal Free Ctr HIV Med, London NW3 2PF, England

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2001年 / 47卷 / 04期

关键词：

D O I：

10.1093/jac/47.4.371

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页码：371 / 375

页数：5

共 22 条

[1]

Aber V, 1996, LANCET, V348, P283, DOI 10.1016/S0140-6736(96)05387-1

[2] The Women's Interagency HIV Study [J].

Barkan, SE ;

Melnick, SL ;

Preston-Martin, S ;

Weber, K ;

Kalish, LA ;

Miotti, P ;

Young, M ;

Greenblatt, R ;

Sacks, H ;

Feldman, J .

EPIDEMIOLOGY, 1998, 9 (02) :117-125

[3]

Cameron DW, 1999, AIDS, V13, P213, DOI 10.1097/00002030-199902040-00009

[4] Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study [J].

Egger, M ;

Hirschel, B ;

Francioli, P ;

Sudre, P ;

Wirz, M ;

Flepp, M ;

Rickenbach, M ;

Malinverni, R ;

Vernazza, P ;

Battegay, M ;

Bernasconi, E ;

Burgisser, P ;

Erb, P ;

Fierz, W ;

Grob, P ;

Gruninger, U ;

Jeannerod, L ;

Ledergerber, B ;

Luthy, R ;

Matter, L ;

Opravil, M ;

Paccaud, F ;

Perrin, L ;

Pichler, W ;

Piffaretti, GC ;

Rutschmann, O ;

Zanetti, G .

BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7117) :1194-1199

[5] THE EFFICACY OF AZIDOTHYMIDINE (AZT) IN THE TREATMENT OF PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

FISCHL, MA ;

RICHMAN, DD ;

GRIECO, MH ;

GOTTLIEB, MS ;

VOLBERDING, PA ;

LASKIN, OL ;

LEEDOM, JM ;

GROOPMAN, JE ;

MILDVAN, D ;

SCHOOLEY, RT ;

JACKSON, GG ;

DURACK, DT ;

KING, D .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (04) :185-191

[6] SURROGATE ENDPOINTS IN CLINICAL-TRIALS - OPHTHALMOLOGIC DISORDERS [J].

HILLIS, A ;

SEIGEL, D .

STATISTICS IN MEDICINE, 1989, 8 (04) :427-430

[7] A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy [J].

Hirsch, M ;

Steigbigel, R ;

Staszewski, S ;

Mellors, J ;

Scerpella, E ;

Hirschel, B ;

Lange, J ;

Squires, K ;

Rawlins, S ;

Meibohm, A ;

Leavitt, R .

JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (03) :659-665

[8] THE MULTICENTER AIDS COHORT STUDY - RATIONALE, ORGANIZATION, AND SELECTED CHARACTERISTICS OF THE PARTICIPANTS [J].

KASLOW, RA ;

OSTROW, DG ;

DETELS, R ;

PHAIR, JP ;

POLK, BF ;

RINALDO, CR .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 126 (02) :310-318

[9] CLINICAL, IMMUNOLOGICAL, AND SEROLOGIC FINDINGS IN MEN AT RISK FOR ACQUIRED-IMMUNODEFICIENCY-SYNDROME - THE SAN-FRANCISCO MENS HEALTH STUDY [J].

LANG, W ;

ANDERSON, RE ;

PERKINS, H ;

GRANT, RM ;

LYMAN, D ;

WINKELSTEIN, W ;

ROYCE, R ;

LEVY, JA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (03) :326-330

[10] EVALUATING THE ROLE OF CD4-LYMPHOCYTE COUNTS AS SURROGATE END-POINTS IN HUMAN-IMMUNODEFICIENCY-VIRUS CLINICAL-TRIALS [J].

LIN, DY ;

FISCHL, MA ;

SCHOENFELD, DA .

STATISTICS IN MEDICINE, 1993, 12 (09) :835-842

← 1 2 3 →